Asthma and COPD Drugs Market Size Forecast 2016 - 2024: Combination Drugs Sales to Constitute Bulk of Revenue
U.S. and China asthma and COPD drugs market to be worth US$18.7 bn by 2024. If these values hold true, the market is likely to expand at a modest CAGR of 4.1% therein.
View full press release